[{"id":"a6fde233-b4ee-45d5-9875-e132271d0525","acronym":"","url":"https://clinicaltrials.gov/study/NCT06096038","created_at":"2023-10-23T18:13:40.077Z","updated_at":"2024-07-02T16:35:08.159Z","phase":"Phase 1/2","brief_title":"Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC","source_id_and_acronym":"NCT06096038","lead_sponsor":"UNC Lineberger Comprehensive Cancer Center","biomarkers":" CSPG4","pipe":"","alterations":" ","tags":["CSPG4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV"],"overall_status":"Recruiting","enrollment":" Enrollment 33","initiation":"Initiation: 04/05/2024","start_date":" 04/05/2024","primary_txt":" Primary completion: 08/01/2026","primary_completion_date":" 08/01/2026","study_txt":" Completion: 08/01/2028","study_completion_date":" 08/01/2028","last_update_posted":"2024-04-23"}]